Skip to content

Schrodinger SDGR Short- term Investments

Short- term Investments at other companies

Absci Corporation logo
Absci CorporationABSI
Septerna, Inc. logo
Septerna, Inc.SEPN
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's short- term investments?
Schrodinger (SDGR) reported short- term investments of $138.7M in Q1 2026.
How has Schrodinger's short- term investments changed year-over-year?
Schrodinger's short- term investments decreased by 20.4% year-over-year, from $174.3M to $138.7M.
What is the long-term trend for Schrodinger's short- term investments?
Over 5 years (2020 to 2025), Schrodinger's short- term investments has grown at a -17.8% compound annual growth rate (CAGR), from $440.4M to $164.95M.